(2E)-3-(2-aminopyrimidin-5-yl)acrylic acid, 95.0%, 250mg

(R)-4-(Iodomethyl)-2,2-dimethyl-1,3-dioxolane, 95.0%, 10g

2-[(2,4-dichlorobenzyl)thio]-4,5-dihydro-1H-imidazole hydrochloride, 95.0%, 500mg

tert-Butyl 6,6-difluoro-2-azaspiro[3.3]heptane-2-carboxylate, 95.0%, 250mg

Bromoacetaldehyde dimethyl acetal, 97.0%, 250g

1-(Cyclohex-1-en-1-yl)piperidine, 95.0%, 1g

3-Hydroxy-1-(4-methoxyphenyl)cyclobutane-1-carboxylic acid, 95%, 50mg

Methyl 4-chloro-1H-indole-2-carboxylate, 95.0%, 5g

1-METHYL-2-METHYLSULPHONYL-5-NITRO-IMIDAZOLE, 97.0%, 100mg

3-Amino-n-[2-(dimethylamino)ethyl]benzene-1-sulfonamide, 97%, 10g

(1S)-1-[4-(DIFLUOROMETHOXY)PHENYL]ETHAN-1-AMINE, 95%, 50mg

Nitrobenceno, mínimo 98,5 %, para síntesis, 500 ml, envase de vidrio

(S)-3,3-Difluoro-1-methylpiperidin-4-ol, 98%, 500mg